← All trials
NCT06744205
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 7, 2025
- Primary completion
- Feb 4, 2026
- Completion date
- May 1, 2026
- First posted
- Dec 20, 2024
- Last posted
- Dec 20, 2024
- Enrollment
- 1158
- Arms / groups
- 11 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sanofi-AventisLead sponsor
- SanofiOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.